Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
BROOMFIELD - A research drug that can help people with Type 2 diabetes control their blood glucose levels did well in a recent clinical trial, according to MicroBiome Therapeutics LLC, the company that's developing the drug.
Broomfield-based MicroBiome reported that the research drug called NM504 kept blood glucose levels within normal limits for patients involved in a four-week clinical trial. The research drug works by shifting a diabetic or pre-diabetic person's gut bacteria to make it behave more like a healthy person's gut bacteria, said Barbara Lindheim, a company spokeswoman.
Studies have shown that Type 2 diabetics typically have microbial imbalances in the gastrointestinal tract, which may contribute to the metabolic dysfunction associated with the condition.
http://www.bcbr.com/article/20140219/NEWS/140219894
Broomfield-based MicroBiome reported that the research drug called NM504 kept blood glucose levels within normal limits for patients involved in a four-week clinical trial. The research drug works by shifting a diabetic or pre-diabetic person's gut bacteria to make it behave more like a healthy person's gut bacteria, said Barbara Lindheim, a company spokeswoman.
Studies have shown that Type 2 diabetics typically have microbial imbalances in the gastrointestinal tract, which may contribute to the metabolic dysfunction associated with the condition.
http://www.bcbr.com/article/20140219/NEWS/140219894